Patents Assigned to Merck, Sharp & Dohms, Corp.
  • Piperidinone carboxamide azaindane CGRP receptor antagonists
    Patent number: 8481556
    Abstract: The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: July 9, 2013
    Assignee: Merck, Sharp & Dohms, Corp.
    Inventors: Ian M. Bell, Mark E. Fraley